Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

SMARTCANCERSENS

Financiado

Cerrado

Micro nanosensors for early cancer warning system diagnostic and prognostic in...

Micro nanosensors for early cancer warning system diagnostic and prognostic information "Oncologists still rely heavily on biological characterisation of tumours and a limited number of biomarkers which have demonstrated clinical utility. Routine cancer diagnostic tools may not be always sensitive enough and may only... ver más

31/12/2016

ITT Dublin

585K€

Presupuesto del proyecto: 585K€

Líder del proyecto

INSTITUTE OF TECHNOLOGY TALLAGHT No se ha especificado una descripción o un objeto social para esta compañía.

Fecha límite participación Sin fecha límite de participación.

Ver 6 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2016-12-31 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

6 Participantes

ITT Dublin

85.80K€ | Lider

URV

N.D. | Participante

UNIVERSITE LYON 1 CLAUDE BER...

N.D. | Participante

TAT

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

RBCE-GENODIAGNOSENS Recuring breast cancer early genetic diagnostic on a chip 159K€ Cerrado

ODASMIR Origami-DNA/AgNCs Sensor for Detection of miRNAs 181K€ Cerrado

SERENA Development of an electrochemical multiSEnsor platform for t... 161K€ Cerrado

EIN2020-112295 DESCUBRIMIENTO DE NUEVOS MARCADORES DE CANCER EN EL PROTEOMA... 15K€ Cerrado

TEC2012-34280 INTEGRACION LAB-ON-A-CHIP DE DISPOSITIVOS BIOFOTONICOS PARA... 138K€ Cerrado

DIAG-CANCER Diagnosis Screening and Monitoring of Cancer Diseases via E... 1M€ Cerrado

Líder del proyecto

INSTITUTE OF TECHNOLOGY TALLAGHT No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 585K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto "Oncologists still rely heavily on biological characterisation of tumours and a limited number of biomarkers which have demonstrated clinical utility. Routine cancer diagnostic tools may not be always sensitive enough and may only detect proteins at levels corresponding to an advanced stage of the disease. Recently, new genomic and proteomic molecular tools (molecular signatures) are being employed which include genetic and epigenetic signatures, changes in gene expression, protein profiles and post-translational modification of proteins. Such advanced diagnostic tools are not always readily adapted to clinical cancer screening due to their complexity, costs and the requirement for highly-qualified operators. Novel bioanalytical methodologies for detection of specific biomarkers/ biomolecules, based on nanostructured electronic sensors (rapid, sensitive devices capable of miniaturisation and deployment on site or in small clinics), fulfill the necessary requirements and have the potential to compliment time- and labour consuming clinical analysers used in medical laboratories currently. The primary objective of this proposal, therefore, is to gather together an international and interdisciplinary consortium of ten research teams from EU Member States, Third (including ENP) countries with EU agreements on S&T, in order to share and jointly exploit knowledge and expertise in the development of micro/nanosensors as tools in early cancer diagnosis. A key scientific target is the realisation of intelligent electronic devices which respond to biomolecules such as formaldehyde, amines, metal ions, saccharides, activities of amine oxidases, arginase and glutathione-S-transferase. This will entail design, development and characterisation of nano-scale transducers suitable for testing in clinical samples."

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores